41
Participants
Start Date
February 5, 2024
Primary Completion Date
July 19, 2024
Study Completion Date
July 19, 2024
Ropanicant
Tablet
CenExel iResearch, LLC, Decatur
CenExel iResearch, LLC, Savannah
Innovative Clinical Research, Inc., Miami Lakes
Precise Research Centers, Flowood
Neuro behavioral Clinical Research, Inc, North Canton
Cedar Clinical Research, Inc., Murray
Collaborative Neuroscience Research, LLC, Torrance
Clinical Innovations, Inc, Bellflower
NRC Research Institute, Orange
Eastside Therapeutic Resource, Inc. dba Core Clinical Research, Everett
Suven Life Sciences Limited
INDUSTRY